$SGMO +26% 🚀 🔹 Genomic medicine play focused on gene therapy, gene editing & gene regulation 🧬 🔹 Recent catalyst: 3 abstracts accepted for ASGCT 2026, highl

$SGMO +26% 🚀 🔹 Genomic medicine play focused on gene therapy, gene editing & gene regulation 🧬 🔹 Recent catalyst: 3 abstracts accepted for ASGCT 2026, highlighting neurology pipeline progress 🔬 🔹 Fabry disease program ST-920 remains the key value driver with rolling BLA submission underway 📄 …